Related Experiment Videos
TIPS: an update
1Praxiszentrum für Gastroenterologie, University Hospital, Bertoldstrasse 48, 79098 Freiburg, Germany. martin-roessle@t-online.de
Summary
Transjugular intrahepatic portosystemic shunt (TIPS) effectively treats portal hypertension and variceal bleeding. Covered stents improve shunt patency, making TIPS a vital rescue therapy for cirrhosis complications like bleeding and ascites.
Area of Science:
- Interventional Radiology
- Hepatology
- Gastroenterology
Background:
- Portal hypertension is a significant complication of cirrhosis.
- Variceal bleeding and refractory ascites are major challenges in managing portal hypertension.
- Transjugular intrahepatic portosystemic shunt (TIPS) has evolved as a key intervention.
Purpose of the Study:
- To review the efficacy and indications of TIPS in managing portal hypertension.
- To highlight the impact of covered stents on TIPS patency rates.
- To discuss the role of TIPS as a rescue treatment for acute variceal bleeding and refractory ascites.
Main Methods:
- Review of current literature on TIPS procedures and outcomes.
- Analysis of data regarding shunt insufficiency and the role of covered stents.
- Evaluation of TIPS as a second-line treatment for variceal re-bleeding and as a primary treatment for refractory ascites.
Main Results:
- Covered stents significantly improve TIPS patency, reaching up to 90%.
- TIPS is a highly effective, minimally invasive rescue treatment for acute variceal bleeding, crucial before multi-organ failure.
- TIPS is indicated for 10-20% of patients experiencing recurrent bleeding despite first-line therapy.
- Five randomized studies suggest comparable survival for TIPS versus paracentesis in refractory ascites, though recommendations remain debated.
Conclusions:
- TIPS, especially with covered stents, is a safe and effective treatment for portal hypertension, variceal bleeding, and refractory ascites.
- Optimal timing of rescue TIPS is critical for achieving hemostasis and preventing complications in cirrhotic patients.
- While TIPS shows promise for refractory ascites, further consensus is needed for definitive recommendations.